Clinical Trial

Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated May 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group. Both groups will complete an eight-week supervised exercise program three times per week. The intervention group will additionally perform self-myofascial release using a foam roller before exercise sessions. Outcomes will include foot function, balance, functional mobility, gait performance, and plantar fascia thickness assessed by ultrasonography before and after the intervention.
Trial Details
NCT Number NCT07414914
Lead Sponsor Izmir Katip Celebi University
Collaborators: Cigli Regional Training Hospital
Conditions Type 2 Diabetes
Enrollment 40 participants
Start Date 2025-11-03
Primary Completion 2026-05-04 (estimated)
Study Completion 2026-05-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-17